Sandbox

  • Industry Partnership

    Anthelmintic discovery Discovery of microbial natural products as next gen anthelmintics, in partnership with Novartis Animal Health

  • Patent

    Larval Development Assay Patent for larval development assay – detection of anthelmintic resistance in parasitic nematodes in grazing animals

  • Industry Partnership

    Plant antifungal discovery Discovery of GUS gene activators to protect against pathogenic fungi in crops, in partnership with Syngenta

  • Patent

    Novel terpenylated diketopiperazines Novel terpenylated diketopiperazines (drimentines) for the treatment of bacteria, fungi, endoparasites and ectoparasites infections, cancer and other malignant diseases in human and animal health, in collaboration with Novartis Animal Health.

  • SPIRT Grant

    Biopesticides for veterinary health Australian Research Council SPIRT grant to explore biopesticides for veterinary health

  • Industry Partnership

    Crop protection discovery Discovery of marine microbial metabolites for crop protection.

  • SPIRT Grant

    Antibiotic discovery Australian Research Council SPIRT grant to explore new antibiotics from Australian microbes

  • 15 Publications

    International Journal for Parasitology International Journal for Parasitology International Journal for Parasitology Biochemistry and Molecular Biology International The Journal of Antibiotics The Journal of Antibiotics International Journal for Parasitology International Journal for Parasitology International Journal for Parasitology Tetrahedron The Journal of Antibiotics Journal of Organic Chemistry The Journal of Antibiotics International Journal for Parasitology Journal […]

  • Patent

    Protection of plants against microorganism attack Protection and immunization of plants against attack by phytopathogenic microorganisms, in partnership with Novartis

  • Patent

    New use as antihelmintics of albofungin and analogs New use as an antihelmintics of albofungin and analogues as anthelmintics, in partnership with Novartis Animal Health.

  • Industry Partnership

    Anti-cancer discovery Isolation and structural elucication of tigilanol tiglate, later commercialised for topical use as an anticancer agent in animals by Ecobiotics.

  • Patent

    Novel biocide compound, isonemadectin, and uses thereof. Patent for novel biocide compound, isonemadectin, and analogues and uses thereof.

  • Commercial venture

    Drenchrite Larval Development Assay Commercialisation of the larval development and larval motility assays for infield assesment of drug resistance in parasite populations

  • Industry Partnership

    Identification of food contaminant Identification of contaminant in dog food causing significant toxicity.

  • Industry Partnership

    Milk industry biodiscovery Discovery of unique, biologically active compounds in milk, in partnership with IMB and Murray Goulburn Cooperative Co Ltd.

  • Patent

    Polyketide xanthones and uses thereof. Polyketide xanthones of the kibdelone class and their use as antibacterial and anticancer agents, in collaboration with IMB.

  • Industry Partnership

    Antibiotic discovery Partnership with Betabiotics Pty Ltd to conduct antibiotic discovery

  • Commercial venture

    Launch of BioAustralis fine chemicals (BIA) Launch of BioAustralis Fine Chemicals, selling known metabolites isolated during MST’s discovery program as laboratory research tools.

  • ARC linkage

    Next generation anthelmintics Australian Research Council Linkage grant with IMB for discovery of next generation anthelmintics

  • Strategic Partnership

    BIA fine chemicals for drug discovery Provision of a comprehensive standards library to Biotica Ltd support novel drug discovery

  • Industry Partnership

    Metabolite chemistry – commercial product Characterisation of metabolites of Duddingtonia flagrans for commercial use as an animal health product

  • ARC linkage

    Growing a sustainable new molecular resource Australian Research Council Linkage grant with IMB for drug discovery

  • Strategic Partnership

    BioAustralis laboratory fine chemicals Provision of the full range of BioAustralis fine chemicals to a major U.S. life sciences company

  • Strategic Partnership

    BIA fine chemicals for biocontrol discovery Integration of the former Merck natural product plant library into MST’s existing libraries

  • Strategic Partnership

    BioAustralis laboratory drug discovery Provision of a library containing known metabolites to support the biocontrol program of a major European multinational

  • CRC-P

    Topical probiotic acaricide discovery CRC-P grant to deliver Probio-TICK, a sustainable microbial probiotic against cattle tick and buffalo fly for northern Australia, in collaboration with Meat and Livestock Australia and Macquarie University.

  • CRC-P

    5,000 BioAustralis laboratory fine chemicals A CRC-P grant to significantly expand the BioAustralis offering of microbial metabolites, in collaboration with University of Western Australia, Macquarie University and Advanced Veterinary Therapeutics.

  • Strategic Partnership

    BIA fine chemicals for biocontrol discovery Preparation of custom library of known and novel microbial metabolites to investigate plant antifungal potential.

  • Patent

    Probiotic compositions Composition of bacterial organisms active against ectoparasites, emanating from the probiotic CRC-P.

  • 6 innovation patents

    A range of Australian innovation patents from the research conducted into antivirals, nematocides and anti-protozoans.

  • Strategic Partnership

    BIA fine chemicals for biocontrol discovery Preparation of a custom library of known plant antifungals to support biocontrol discovery and development

  • Industry Partnership

    Cryptic metabolite discovery An expansive biodiscovery project producing one of the most granular maps of microbial biodiversity across a continent.

  • Industry Partnership

    Biostimulant discovery Discovery of biostimulant microorganisms for agricultural use

  • ARC linkage grant

    Advanced biomanufacturing An ARC linkage grant with University of Western Australia to enhance the production of cryptic metabolites

  • Biotech Innovation Fund Grant

    Chemotherapy discovery Biotech Innovation Fund grant to investigate nuclear export of proteins as a target in chemotherapy

  • Acquisition

    Acquisition of a library of 25,000 milled and dried Australian plants.

  • Acquisition

    Merck plant library Acquisition of the former Merck natural product plant library.

  • Commercial agreement

    Licensing of a microbial strain for use as a biostimulant in agriculture.